Zoetis (ZTS) EBT Margin Growth (3y) (2015 - 2026)
Zoetis (ZTS) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -4,603.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -491.00 |
| Mar 31, 2026 | -134.00 |
| Dec 31, 2025 | 286.00 |
| Sep 30, 2025 | 364.00 |
| Jun 30, 2025 | 402.00 |
| Mar 31, 2025 | -144.00 |
| Dec 31, 2024 | 587.00 |
| Sep 30, 2024 | 348.00 |
| Jun 30, 2024 | 39.00 |
| Mar 31, 2024 | -261.00 |
| Dec 31, 2023 | 613.00 |
| Sep 30, 2023 | -9.00 |
| Jun 30, 2023 | 886.00 |
| Mar 31, 2023 | 245.00 |
| Dec 31, 2022 | 291.00 |
| Sep 30, 2022 | -2.00 |
| Jun 30, 2022 | 324.00 |
| Mar 31, 2022 | 1,042.00 |
| Dec 31, 2021 | -100.00 |
| Sep 30, 2021 | 487.00 |